Dawson James analyst Jason Kolbert downgrades Aditxt (NASDAQ:ADTX) from Buy to Neutral.
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $283
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $239 to $283.